HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

acamprosate (AOTA)

Subscribe to New Research on acamprosate

reduces voluntary ethanol intake by rats

Also Known As:

AOTA; Campral; AWD.pharma brand of acamprosate calcium; Almirall brand of acamprosate calcium; Alphapharma brand of acamprosate calcium; Aotal; Campral EC; Lipha brand of acamprosate calcium; Merck Lipha Santé brand of acamprosate; Merck brand of acamprosate calcium; N-acetylhomotaurine; N-acetylhomotaurine, calcium (2:1) salt; N-acetylhomotaurine, magnesium (2:1) salt; N-acetylhomotaurine, monolithium salt; N-acetylhomotaurine, monopotassium salt; N-acetylhomotaurine, monosodium salt; N-acetylhomotaurine, zinc (2:1) salt; Zulex; acamprosate calcium; acamprostate; calcium acetyl homotaurinate; calcium acetylhomotaurinate; calcium acetylhomotaurine; sodium acetylhomotaurine

Networked: 163 relevant articles (17 outcomes, 32 trials/studies)

Relationship Network

Drug Context: Research Results

Organic Chemicals: 58
- Hydrocarbons: 412
  - Acyclic Hydrocarbons
    - Alkanes: 64
      - Alkanesulfonic Acids
        Taurine: 2165
        acamprosate: 163
- Sulfur Compounds: 135
  - Sulfur Acids
    - Sulfonic Acids: 3
      - Alkanesulfonic Acids
        Taurine: 2165
        acamprosate: 163

Experts

1.	Kiefer, Falk: 8 articles (04/2009 - 01/2003)
2.	Lehert, Philippe: 7 articles (03/2012 - 11/2004)
3.	Mason, Barbara J: 6 articles (02/2015 - 08/2006)
4.	Erickson, Craig A: 5 articles (12/2014 - 11/2010)
5.	McDougle, Christopher J: 5 articles (12/2014 - 11/2010)
6.	Heilig, Markus: 5 articles (03/2014 - 01/2002)
7.	Wiedemann, Klaus: 5 articles (08/2006 - 01/2003)
8.	Wink, Logan K: 4 articles (12/2014 - 12/2011)
9.	Savage, Julian: 4 articles (01/2014 - 01/2007)
10.	Jahn, Holger: 4 articles (08/2006 - 01/2003)

Related Diseases

1.	Alcoholism (Alcohol Abuse) 09/01/2012 - "GlyT-1 inhibition may represent a new treatment principle for alcoholism that is superior to acamprosate." 10/09/2003 - "Acamprosate has been shown to be effective and safe in relapse prevention of alcoholism. " 01/01/2002 - "Exposure-induced but not spontaneous alcohol intake is antagonized by acamprosate, a compound clinically effective in human alcoholism. " 02/01/1998 - "Acamprosate (calcium-acetyl homotaurinate) is a relatively new compound developed for the treatment of alcoholism and has been shown to be effective in attenuating relapse in human alcoholics. " 05/01/2000 - "The properties of acamprosate (calcium acetylhomotaurate), a new remedy for the treatment of alcoholism, are reviewed. "
2.	Tinnitus 01/01/2012 - "(1)To study the effectiveness of acamprosate in providing subjective relief and objective improvement in patients having tinnitus of sensorineural origin. " 08/16/2014 - "Acamprosate may decrease the severity of tinnitus, but the level of evidence is low. " 01/01/2012 - "Acamprosate is an effective drug in treating the severity of sensorineural tinnitus without causing much of the side effects." 01/01/2012 - "The effect of acamprosate and placebo on subjective relief and objective improvement was evaluated by using modified tinnitus severity, QOL scores and audiometry with tinnitus matching in frequency and loudness. " 01/01/2012 - "Role of acamprosate in sensorineural tinnitus."
3.	Stroke (Strokes) 09/01/2000 - "In contrast, acamprosate improved neurological outcome, with stroke-related death occurring in one animal only and a minor neurological deficit in the surviving rats. " 12/01/2015 - "Taken into account its excellent tolerability, its sustained effects on neurologic recovery, brain tissue survival, and neural remodeling, acamprosate is an intriguing candidate for adjuvant future stroke treatment. " 12/01/2015 - "Acamprosate yielded sustained neuroprotection and increased neurologic recovery when given no later than 12 hours after stroke. " 01/01/2016 - "The American Occupational Therapy Association (AOTA) Evidence-Based Practice Project has developed a table summarizing the research opportunities on adults with stroke. " 09/01/2015 - "Findings from the systematic reviews on this topic were published in the January/February 2015 issue of the American Journal of Occupational Therapy and in AOTA's Occupational Therapy Practice Guidelines for Adults With Stroke (Wolf & Nilsen, 2015). "
4.	Overweight 10/01/2015 - "In conclusion, acamprosate may be beneficial for participants with shorter abstinence who are not overweight or obese. "
5.	Multiple Sclerosis 02/01/2012 - "This pilot study aimed to determine the efficacy of acamprosate (N-acetyl homotaurine) in reducing the pathological features of experimental autoimmune encephalomyelitis (EAE) which is an animal model for multiple sclerosis (MS). "

Related Drugs and Biologics

1.	Naltrexone (ReVia)
2.	Baclofen
3.	Disulfiram (Antabuse)
4.	homotaurine
5.	Carbon Monoxide
6.	topiramate (Topamax)
7.	gamma-Aminobutyric Acid (GABA)
8.	beta-Endorphin (Endorphin, beta)
9.	Brain-Derived Neurotrophic Factor (BDNF)
10.	Pregnanolone (Allopregnanolone)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Occupational Therapy (Therapy, Occupational)
3.	Hypnosis (Mesmerism)
4.	Hearing Aids (Hearing Aid)
5.	Injections